Please assess the completion status of the following clinical trial:

Trial Title: Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing theraputic manipulation for adhesive capsulitis of the shoulder~* age 18 years or older~* accepting a single-injection nerve block for manipulation~* understanding possible perineural infusion-related complications, study protocol, and catheter/pump care~* having caretaker through the first night after manipulation~* having an ASA physical status classification of 1-3~Exclusion Criteria:~* Any contraindications for a CISB~* any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery~* known allergy or other contraindication to the study medications~* pregnancy~* known hepatic or renal insufficiency/disease~* peripheral neuropathy of the surgical extremity~* morbid obesity~* inability to communicate with the investigators and hospital staff~* moderate-to-severe shoulder arthritis~* immunocompromised status of any etiology~* incarceration

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1. 0.2% Ropivicaine perinueral infusion (Type: ACTIVE_COMPARATOR): Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to 0.2% Ropivicaine attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.
- 2. Normal Saline perineural infusion (Type: PLACEBO_COMPARATOR): Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy). They will then be randomized to normal saline attached to the perineural catheter and an infusion will be initiated. The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.

Based on this trial design, predict the completion outcome and termination type (if applicable).